Unggahan by Deep Run Waters

Vivesto Q2

Karolinska development report for 2022 Part 2

Karolinska Development report 2022 part 1

interim-report-q1-2018-180831

2 Final-poster Mon-po 294 Isth2015

DPI Top line results.pdf

The Complete Newbies Guide to Pheromones

Dixon Corporate Presentation Oct 17

SPARC Press Release USFDA Approval for ELEPSIA XR

Intimation Bse Approval

DPI Top Line Results

SPARC_Press Release_6!10!17 Final for Release

Investor Update on R&D Pipeline 24th August Final

Outcome of Board Meeting December 6 2017

Intimation for Board Meeting November 14 2017

Cll Results q3 Fy17

Clarislife Results Q4

Pr Convertible 171130

Interim Report q2 2017 Final

interim-report-q1-maj17-juli17-.pdf

KD Q3 2017 ENG FINAL.pdf

PR_KD_CFO

KD New CEO

KD Invite to Concall

KD Umercrine Fund Raising

XSpray Sale of Shares (ENG)

Kd q3 2017 Eng Final

KD Bioarctic Sale of Shares

170728_EN_HYR-2017_Final

171017 Pr Spepharm Vdef

Asidna and Onxeo

180918 PR Call Relive Data

170913 en Validive-Monopar FINAL

PB_Q4_2014_ENG

PB_Q3_2014_ENG

IDirect_FirstSource_Q2FY17

813720 Karolin Dev 6 Months

SeQuent PR Q118 Final

Praj Industries 180817

Interim Report q1 Maj17 Juli17

Karolinska Development Annual Report En

SPARC Investor Presention 4th August Final